Acute Renal Injury During High Intensity Training
HIFRT-KH
Hematological Risk Factors Related to Acute Renal Injury During High Intensity Training
1 other identifier
interventional
42
1 country
1
Brief Summary
The proposed work is designed to be the first in a series of studies investigating the health benefits and risks related to high intensity training (HIT) exercise. Our specific aims are to determine, 1) if participation in a single bout of HIT induces hematological markers consistent with acute kidney injury (AKI), and 2) if risk is predicted by the pre-exercise concentration of plasma proenkephalin-A. This investigation is an observational case control study. In year one, data collection procedures will be refined with \~40 participants local to the University of Wyoming and training will occur for collaborators from Wyoming community and tribal colleges. In year two, data collection will expand to some of the 12 CrossFit® gyms in Wyoming with assistance from the community and tribal colleges. Blood and urine samples will be collected before and up to 48 h after a standardized bout of HIT exercise on \~100 participants. Baseline blood samples will be analyzed for proenkephalin-A. All blood samples will be analyzed for markers of muscle damage (e.g., creatine kinase and myoglobin), and markers of kidney function (e.g., serum creatinine and blood urea nitrogen). Urine will be analyzed for markers of filtration function (e.g., albumin, creatinine, neutrophil gelatinase-associated lipocalin \[NGAL\], and kidney injury molecule 1 \[KIM-1\]). Lastly, the severity of kidney damage will be compared with the number of risk alleles and proenkephalin-A concentration. The investigators envision that the bout of HIT exercise will induce markers consistent with skeletal muscle damage in most participants and, based on literature from other styles of intense exercise, that acute kidney injury will be diagnosable in between 50-75% of participants. Secondarily, the investigators predict that the concentration of proenkephalin-A will be inversely related to the change in kidney function from before to after the HIT exercise bout.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Oct 2018
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 30, 2018
CompletedFirst Posted
Study publicly available on registry
September 19, 2018
CompletedStudy Start
First participant enrolled
October 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 30, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2019
CompletedResults Posted
Study results publicly available
April 19, 2021
CompletedJuly 16, 2021
June 1, 2021
8 months
August 30, 2018
January 5, 2021
June 28, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Change in Concentration of Proenkephalin-A From Baseline to 4 Time-points Surrounding the Workout
an endogenous opioid polypeptide hormone which, via proteolytic cleavage, produces the enkephalin peptides \[Met\]enkephalin, and to a lesser extent, \[Leu\]enkephalin.
Baseline, Immediately pre-exercise, immediately post-exercise, 24 hours post-exercise, 48 hours post-exercise
Change in Serum Creatinine
Marker of kidney function measured as a change in concentration between baseline to 4 time-points surrounding the workout
Baseline, Immediately pre-exercise, immediately post-exercise, 24 hours post-exercise, 48 hours post-exercise.
Change in Creatinine Kinase
Marker of skeletal muscle damage measured as a change in concentration between baseline and 4 time-points surrounding exercise
Baseline, Immediately pre-exercise, immediately post-exercise, 24 hours post-exercise, 48 hours post-exercise
Change in 24 Hour Urinary Kidney Injury Molecule 1
Marker of Kidney Injury measured as a change in concentration between baseline to 2 time points surrounding exercise
Baseline, Day 2, Day 3
Change in 24 Hour Urinary Neutrophil Gelatinase-associated Lipocalin
Marker of kidney damage measured as a change in concentration between baseline and 2 time points surrounding the exercise
Baseline, Day 2, Day 3
Secondary Outcomes (2)
Change in the Short-form McGill Pain Questionnaire
Baseline, immediately pre-exercise, immediately post-exercise, 24 hours post-exercise, 48 hours post-exercise
Post Exercise Hypotension
Baseline, immediately pre-exercise, immediately post-exercise, 24 hours post-exercise, 48 hours post-exercise
Study Arms (1)
HIFRT Workout
EXPERIMENTALConsecutive completion of; 1 mile run, 100 pull ups, 200 push-ups, 300 bodyweight squats, 1 mile run.
Interventions
A single high intensity functional resistance training (HIFRT) exercise bout.
Eligibility Criteria
You may qualify if:
- \. Healthy individual who has completed this specific workout on at least one prior occasion
You may not qualify if:
- Score of "0" on the Functional Movement Screening (FMS) test as evaluated by two investigators \* indicating pain during any of the seven functional movements
- Self- reported Kidney (chronic kidney disease, polycystic kidney disease, glomerulonephritis, diabetic nephropathy, interstitial nephritis, Goodpasture syndrome) or other medical condition contraindicating participation in HIFRT (Hypertension, dyslipidemia, type II diabetes mellitus, BMI \>30)
- Pregnancy, suspected pregnancy, or breastfeeding
- Blood donations within the last eight weeks leading up to testing day
- Any musculoskeletal injuries which have resulted in \> 1 week of absence from HIFRT within the last six months
- Not passing the physical activity readiness questionnaire (PAR-Q)
- Allergy to ibuprofen or non-steroidal anti-inflammatory medication
- Surgical operation on digestive tract or kidneys, except appendectomy
- Inability to participate in the entire study
- Recurrent urinary tract infections or kidney stones
- History of protein or blood in urine
- Moving from a location of low altitude (\< 3,000') to Laramie within the past 3 months
- Inability to understand and write English
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Wyominglead
- Lund Universitycollaborator
Study Sites (1)
University of Wyoming
Laramie, Wyoming, 82071, United States
Related Publications (4)
Poston WS, Haddock CK, Heinrich KM, Jahnke SA, Jitnarin N, Batchelor DB. Is High-Intensity Functional Training (HIFT)/CrossFit Safe for Military Fitness Training? Mil Med. 2016 Jul;181(7):627-37. doi: 10.7205/MILMED-D-15-00273.
PMID: 27391615BACKGROUNDBergeron MF, Nindl BC, Deuster PA, Baumgartner N, Kane SF, Kraemer WJ, Sexauer LR, Thompson WR, O'Connor FG. Consortium for Health and Military Performance and American College of Sports Medicine consensus paper on extreme conditioning programs in military personnel. Curr Sports Med Rep. 2011 Nov-Dec;10(6):383-9. doi: 10.1249/JSR.0b013e318237bf8a.
PMID: 22071400BACKGROUNDMansour SG, Verma G, Pata RW, Martin TG, Perazella MA, Parikh CR. Kidney Injury and Repair Biomarkers in Marathon Runners. Am J Kidney Dis. 2017 Aug;70(2):252-261. doi: 10.1053/j.ajkd.2017.01.045. Epub 2017 Mar 28.
PMID: 28363731BACKGROUNDSchulz CA, Christensson A, Ericson U, Almgren P, Hindy G, Nilsson PM, Struck J, Bergmann A, Melander O, Orho-Melander M. High Level of Fasting Plasma Proenkephalin-A Predicts Deterioration of Kidney Function and Incidence of CKD. J Am Soc Nephrol. 2017 Jan;28(1):291-303. doi: 10.1681/ASN.2015101177. Epub 2016 Jul 8.
PMID: 27401687BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr. Evan Johnson
- Organization
- University of Wyoming
Study Officials
- PRINCIPAL INVESTIGATOR
Evan C Johnson, PhD
University of Wyoming
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Masking Details
- No other parties besides the participants will be masked.
- Purpose
- SCREENING
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 30, 2018
First Posted
September 19, 2018
Study Start
October 1, 2018
Primary Completion
May 30, 2019
Study Completion
June 30, 2019
Last Updated
July 16, 2021
Results First Posted
April 19, 2021
Record last verified: 2021-06
Data Sharing
- IPD Sharing
- Will not share